Hendrik Treede
Latest contributions
Emerging indications for TAVI in 2025
22 May 2025 – From EuroPCR 2025
Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.
Innovation to address unmet clinical needs in transcatheter valve therapies
22 May 2025 – From EuroPCR 2025
Discover innovations addressing unmet clinical needs in transcatheter valve therapies. This session shares case-based experiences including young aortic stenosis patients, mitral regurgitation with annular calcification, and severe tricuspid regurgitation with right ventricular dysfunction, alongside the latest advances in TAVI, TMVR, and tricuspid interventions.
TAVI in difficult scenarios: bicuspid anatomy and pure aortic regurgitation
22 May 2025 – From EuroPCR 2025
Address challenging TAVI scenarios involving bicuspid anatomy and pure aortic regurgitation with insights from international experiences. This session compares treatment options in China and Germany, explores anatomical and disease differences, and reviews various TAVI devices through detailed case presentations and expert commentary.
Innovations in TMVR and Intrepid trial updates
21 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session highlights the evolving role of transcatheter mitral valve replacement, focusing on the clinical potential of mitral regurgitation elimination. Get an overview of the current status of the Intrepid TMVR programme, learn about the transition to the 29Fr transfemoral system, and explore how...
TAVI in bicuspid aortic valve disease - LIVE Case
20 May 2025 – From EuroPCR 2025
A 79-year-old male patient with atrial fibrillation and RBBB on ECG presented with symptomatic severe bicuspid aortic stenosis. LV function was preserved, and coronary artery disease was noted in LAD and first diagonal. A 26 mm Sapien Ultra Resilia valve was implanted via dual femoral access,...
Recurrent and residual tricuspid regurgitation after transcatheter repair - Assessment and management
26 Nov 2024 – From PCR London Valves 2024
Join us as we delve into the critical topic of recurrent and residual tricuspid regurgitation after transcatheter repair. Gain valuable insights on how to avoid these complications, learn to assess the underlying mechanisms and severity, and explore the latest options for interventional treatment. This session, developed...
TAVI for pure aortic regurgitation with a dedicated CE-mark device: an underdiagnosed and undertreated disease
26 Nov 2024 – From PCR London Valves 2024
Explore this session to learn about the unmet needs in aortic regurgitation (AR) and the performance of dedicated TAVI devices for AR. Discover why new thresholds for severe AR are necessary, and how traditional methods may underestimate its severity. Gain insights into the TRILOGY THV system,...
SAVR or TAVR: what is best for female patients?
25 Nov 2024 – From PCR London Valves 2024
Wondering which is the better option for female patients—SAVR or TAVR? Don’t miss this exchange between Hendrik Treede and Hélène Eltchaninoff. They explore the unique challenges and nuances of valve interventions for women, highlighting evolving strategies to optimize treatment and improve outcomes.
You may also be interested...
Recurrent and residual mitral regurgitation after transcatheter repair - Assessment and management
25 Nov 2024 – From PCR London Valves 2024
Struggling with recurrent or residual mitral regurgitation after transcatheter repair? This video answers your questions with actionable strategies to assess, prevent and treat this challenging condition.
Learn how to pinpoint the mechanisms and severity of mitral regurgitation using advanced imaging, hear what interventionalists need to know to...
New frontiers in TAVI: have we reached them?
25 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in TAVI as we look into the results of the EARLY TAVR and RHEIA trials. Explore how these groundbreaking findings may influence clinical practice guidelines and shape the future of TAVI, as well as the remaining unmet clinical needs in TAVI.
Minimally invasive mitral valve surgery - Staying ahead of the game
25 Nov 2024 – From PCR London Valves 2024
Ready to stay ahead in minimally invasive mitral valve surgery? Don't miss this video!
You’ll explore advanced surgical treatment options for valve diseases, learn how the pathophysiology of mitral and tricuspid regurgitation impacts surgical repair techniques, weigh the pros and cons of interventional and surgical approaches for...
TAVI in women - Recent trials and current understanding
25 Nov 2024 – From PCR London Valves 2024
Looking to learn more about gender-based differences in the presentation and management of aortic stenosis? Dont' miss this video on the specifics of TAVI in women!
You'll discover how aortic stenosis presents uniquely in female patients, review the latest data on TAVI outcomes in women, and gain...
New evidence on TAVI from PCR Companions
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 abstract submissions presenting the latest evidence on TAVI. Topics include device success in valve-in-valve TAVI, next-day discharge after TAVI, comparative network meta-analysis of PCI strategies in TAVI patients, factors associated with thrombosis treatment response, and outcomes of a novel balloon-expandable...
To repair or to replace the mitral valve: that is the question
16 May 2024 – From EuroPCR 2024
This session provides a comprehensive understanding of both transcatheter edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) techniques, including their respective advantages, suitability criteria, and clinical outcomes. The session features insights from a surgeon's perspective on the considerations and techniques involved in mitral valve repair...
Mitral and tricuspid hotline
16 May 2024 – From EuroPCR 2024
This session provides updates on the latest developments in transcatheter mitral and tricuspid valve interventions. Key topics include one-year outcomes of the MiCLASP study on transcatheter mitral repair, the impact of residual mitral and tricuspid regurgitation after transcatheter repair, and the early feasibility of the AltaValve...
Innovations in TMVR and Intrepid trial updates
14 May 2024 – From EuroPCR 2024
Tune in to this session for comprehensive updates on APOLLO and Intrepid TF, along with invaluable lessons gleaned. Discover insights on patient screening for Intrepid TMVR, and delve into clinical case reviews highlighting advancements such as updated 29Fr access. Learn about the safety and efficacy of...
Late-breaking trials: TAVI head-to-head
14 May 2024 – From EuroPCR 2024
This session presents the latest findings from several late-breaking trials comparing different transcatheter aortic valve implantation (TAVI) approaches. Topics include outcomes in women with small aortic annuli, the comparison of percutaneous versus surgical treatment for patients with aortic stenosis and coronary disease, the impact of valve...
Heart team discussion for left main PCI
14 May 2024 – From EuroPCR 2024
This session focuses on the role of the heart team in the management of complex left main coronary artery disease. It presents three cases, each with a unique set of challenges, and facilitates a structured discussion with the audience to arrive at the optimal treatment strategy....
Contemporary surgical & transcatheter treatment options for severe aortic regurgitation patients
05 Dec 2023 – From PCR London Valves 2023
Two cardiac surgeons, Hendrik Treede and Michael Reardon, and an echo specialist, Joao Cavalcante, have been invited to share their views on aortic regurgitation management.
So far, surgery remains the gold standard, and they explain why, by also comparing repair and replacement, before discussing the challenge that...
Key questions in aortic valve intervention - How to navigate valve sequencing in younger patients?
21 Nov 2023 – From PCR London Valves 2023
What are the aspects to consider when treating younger patients? In this session, get both the interventional cardiologist's and the surgeon's perspective. What do we know and what do we need to know about valve sequencing and hemodynamics? What about CT planning and execution of redo-TAVI?...
Key questions in aortic valve intervention - What are the surgical and transcatheter treatment options for patients with severe aortic regurgitation?
21 Nov 2023 – From PCR London Valves 2023
Although aortic regurgitation is highly prevalent, it remains under-diagnosed and under-treated. Fortunately, the latest devices should rapidly reverse this trend, both surgically and through transcatheter treatments. Find out more about the options available today, whether surgical or transcatheter, with their benefits and limitations, and how to choose them...
How to treat my patient with combined aortic and mitral valve disease
20 Nov 2023 – From PCR London Valves 2023
Explore this session to gain insights into diverse treatment options for combined heart valve disease. Examine the distinctions between surgical and transcatheter approaches, understanding their nuances, the sequential order of treatment and technical considerations crucial for transcatheter interventions.
TAVI: From simple to complex - LIVE case
20 Nov 2023 – From PCR London Valves 2023
This session explores two clinical cases, providing valuable insights into the essential components of a straightforward and efficient TAVI procedure. Find out more about the application of innovative devices to broaden the scope of aortic valve intervention, facilitating their integration into Heart Team discussions and daily...
Key questions in tricuspid valve intervention - What can cardiologists learn from surgeons when choosing to repair or replace the tricuspid valve?
19 Nov 2023 – From PCR London Valves 2023
Watch this session to explore the latest approaches in surgical and transcatheter tricuspid valve repair and replacement. Gain insights into the influence of right ventricular dysfunction and pulmonary hypertension on post-procedural outcomes, and understand the bleeding risks linked to oral anticoagulation in patients with tricuspid valve...
PCR Tricuspid Focus Group - referral meeting in Mainz
10 Jul 2023
Join your peers for this meeting on 7 September 2024 in Mainz, Germany!
Emerging indications for TAVI
18 May 2023 – From EuroPCR 2023
Consult this session if you want to learn about emergent indications of transcatheter treatment of aortic valve disease, to appreciate current gaps in the evidence base and hear about upcoming clinical trials, and to highlight new technologies that will address these treatment gaps.
All you need to know about transcatheter treatment solutions for mitral regurgitation
18 May 2023 – From EuroPCR 2023
Consult this session for a comprehensive understanding of mitral regurgitation including anatomy, pathophysiology, imaging interpretation for diagnosis, intervention selection and procedure guidance, and identifying future unmet needs, illustrated with a series of case examples.
Which valve for which patient? - Part 2: complex anatomy
17 May 2023 – From EuroPCR 2023
Consult this session if you want to understand how to optimize the hemodynamic performance after VinV procedures, to identify patients at risk for coronary occlusion and how to prevent this in VinV procedures, and to learn how to gain safe vascular access in challenging peripheral anatomies.
TAVI for bicuspid anatomy: beyond type I LR
17 May 2023 – From EuroPCR 2023
Consult this session if you want to understand the challenges of bicuspid aortic stenosis patients, type 0 in particular, to review contemporary sizing methods in bicuspid aortic stenosis, and to tailor the implant technique to individual patient.
TAVI in patients with long-life expectancy - LIVE case
16 May 2023 – From EuroPCR 2023
Watch the case of a 75-year-old male patient with history of TIA, symptomatic severe aortic stenosis with RBBB, and preserved LV function. The heart team's decision was to perform TAVI with PCI on LAD a few days before procedure.
First, a cerebral protection device (Sentinel) was implanted....
